Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Robert J Herbert

Biographic Data

ID5545961
NAMERobert J Herbert
GIVEN NAMESRobert J
FAMILY NAMEHerbert
SIGNATUREHERBERT R J
AFFILIATIONSJohns Hopkins University
VERIFIEDNo
TOTAL WORKS4
TOTAL CITATIONS0
AUTHOR COUNT4
EDITOR COUNT0
FIRST PUBLICATION YEAR1991
LATEST PUBLICATION YEAR2011
H-INDEX0
  • Hospice Care and Resource Utilization in Medicare Beneficiaries With Heart Failure

    Saul Blecker, Gerald F Anderson et al.•ARTICLE•Medical Care•2011•References: 34

    BACKGROUND: Although hospice use may be increasing among heart failure patients, its association with both cost and intensity of care in this population has not been well examined. OBJECTIVE: To assess the association of hospice care with resource utilization among a national sample of Medicare beneficiaries with heart failure during the last 6 months of life. METHODS: We performed a cross-sectional analysis of the 5% sample of Medicare claims da…

  • Using Propensity Scores Subclassification to Estimate Effects of Longitudinal Treatments

    Jodi B Segal, Michael Griswold et al.•ARTICLE•Medical Care•2007•References: 18

    BACKGROUND: When using observational data to compare the effectiveness of medications, it is essential to account parsimoniously for patients' longitudinal characteristics that lead to changes in treatments over time. OBJECTIVES: We developed a method of estimating effects of longitudinal treatments that uses subclassification on a longitudinal propensity score to compare outcomes between a new drug (exenatide) and established drugs (insulin and …

  • The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients

    Gregory de Lissovoy, Neil R Powe et al.•ARTICLE•Medical Care•1994

    Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…

  • Accuracy of Medicare Claims Data for Estimation of Cancer Incidence and Resection Rates Among Elderly Americans

    Jeff Whittle, Earl P Steinberg et al.•ARTICLE•Medical Care•1991

    To explore the reliability of Medicare Part A claims data for clinical and health services research related to the care of patients with cancer, the authors compared estimates of the incidence of and resection rates for cancer of the breast, colon, and lung derived from analysis of Medicare Part A data versus data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Incidence rates of breast, colon, and…

No prominent works on this page.

  • Accuracy of Medicare Claims Data for Estimation of Cancer Incidence and Resection Rates Among Elderly Americans

    Jeff Whittle, Earl P Steinberg et al.•ARTICLE•Medical Care•1991

    To explore the reliability of Medicare Part A claims data for clinical and health services research related to the care of patients with cancer, the authors compared estimates of the incidence of and resection rates for cancer of the breast, colon, and lung derived from analysis of Medicare Part A data versus data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Incidence rates of breast, colon, and…

  • The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients

    Gregory de Lissovoy, Neil R Powe et al.•ARTICLE•Medical Care•1994

    Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…

  • Using Propensity Scores Subclassification to Estimate Effects of Longitudinal Treatments

    Jodi B Segal, Michael Griswold et al.•ARTICLE•Medical Care•2007•References: 18

    BACKGROUND: When using observational data to compare the effectiveness of medications, it is essential to account parsimoniously for patients' longitudinal characteristics that lead to changes in treatments over time. OBJECTIVES: We developed a method of estimating effects of longitudinal treatments that uses subclassification on a longitudinal propensity score to compare outcomes between a new drug (exenatide) and established drugs (insulin and …

  • Hospice Care and Resource Utilization in Medicare Beneficiaries With Heart Failure

    Saul Blecker, Gerald F Anderson et al.•ARTICLE•Medical Care•2011•References: 34

    BACKGROUND: Although hospice use may be increasing among heart failure patients, its association with both cost and intensity of care in this population has not been well examined. OBJECTIVE: To assess the association of hospice care with resource utilization among a national sample of Medicare beneficiaries with heart failure during the last 6 months of life. METHODS: We performed a cross-sectional analysis of the 5% sample of Medicare claims da…

Internal Medicine (4 works) · Internal Medicine (4 works) · Medicine (4 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Confidence interval (2 works) · Emergency Medicine (2 works) · Emergency Medicine (2 works) · Environmental health (2 works) · Incidence (geometry) (2 works) · Medical prescription (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae